Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Chugai Pharmaceutical Return on Tangible Equity 2020-2025 | CHGCY

Current and historical return on tangible equity values for Chugai Pharmaceutical (CHGCY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Chugai Pharmaceutical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $2.83B $12.47B 25.42%
2024-03-31 $2.64B $10.87B 25.66%
2023-03-31 $2.61B $10.77B 27.60%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $85.665B $7.742B
CHUGAI PHARMACEUTICAL CO. LTD. is mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products for treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. CHUGAI PHARMACEUTICAL CO. LTD. is based in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.819B 28.29
Daiichi Sankyo, - (DSNKY) Japan $49.559B 25.21
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Sandoz Group AG (SDZNY) Switzerland $22.493B 0.00
Merck (MKKGY) Germany $16.918B 12.40
Summit Therapeutics (SMMT) United States $15.314B 0.00
United Therapeutics (UTHR) United States $14.624B 12.94
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.371B 42.37
Orion OYJ (ORINY) Finland $9.913B 26.81
IPSEN (IPSEY) France $9.890B 0.00
Corcept Therapeutics (CORT) United States $7.371B 59.92
Stevanato Group S.p.A (STVN) Italy $6.599B 40.35
Madrigal Pharmaceuticals (MDGL) United States $6.315B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.734B 0.00
Ionis Pharmaceuticals (IONS) United States $5.532B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.900B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.038B 10.65
Crinetics Pharmaceuticals (CRNX) United States $3.006B 0.00
Hypermarcas (HYPMY) Brazil $2.829B 18.61
BioCryst Pharmaceuticals (BCRX) United States $2.342B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.335B 12.63
NewAmsterdam Pharma (NAMS) Netherlands $2.098B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.784B 0.00
Indivior (INDV) United States $1.748B 7.41
Dyne Therapeutics (DYN) United States $1.508B 0.00
Evotec AG (EVO) Germany $1.431B 0.00
ARS Pharmaceuticals (SPRY) United States $1.427B 0.00
Guardian Pharmacy Services (GRDN) United States $1.380B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.081B 21.62
Harrow (HROW) United States $1.076B 0.00
Enliven Therapeutics (ELVN) United States $1.073B 0.00
Ardelyx (ARDX) United States $0.940B 0.00
Collegium Pharmaceutical (COLL) United States $0.939B 5.07
Avadel Pharmaceuticals (AVDL) Ireland $0.912B 0.00
Akebia Therapeutics (AKBA) United States $0.898B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Xeris Biopharma Holdings (XERS) United States $0.727B 0.00
KalVista Pharmaceuticals (KALV) United States $0.664B 0.00
Xencor (XNCR) United States $0.651B 0.00
AleAnna (ANNA) United States $0.631B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Relay Therapeutics (RLAY) United States $0.564B 0.00
Theravance Biopharma (TBPH) United States $0.556B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.552B 0.00
Bioventus (BVS) United States $0.547B 13.88
Zevra Therapeutics (ZVRA) United States $0.485B 0.00
Tourmaline Bio (TRML) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Oruka Therapeutics (ORKA) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Altimmune (ALT) United States $0.440B 0.00
Verve Therapeutics (VERV) United States $0.431B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 9.85
Organogenesis (ORGO) United States $0.356B 0.00
Aquestive Therapeutics (AQST) United States $0.316B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.296B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.86
MediWound (MDWD) Israel $0.233B 0.00
ProKidney (PROK) United States $0.228B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.179B 0.00
Journey Medical (DERM) United States $0.168B 0.00
OmniAb (OABI) United States $0.167B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.155B 0.00
Larimar Therapeutics (LRMR) United States $0.154B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.139B 0.00
Liminatus Pharma (LIMN) $0.138B 0.00
Wellgistics Health (WGRX) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.094B 0.00
Unicycive Therapeutics (UNCY) United States $0.092B 0.00
Champions Oncology (CSBR) United States $0.089B 14.61
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 64.22
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Dominari Holdings (DOMH) United States $0.064B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
Avalo Therapeutics (AVTX) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
Lyra Therapeutics (LYRA) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
DURECT (DRRX) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.14
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00